Metabolic syndrome as a risk factor for nephrolithiasis
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2024.203849Palabras clave:
Nephrolithiasis, Urolithiasis, Urinary calculi, Metabolic syndromeResumen
Objective: To elucidate the main characteristics of the patient considered to be at high risk for the formation of nephrolithiasis for better targeting in the prevention of this disease. Methods: From September 2019 to October 2020, a prospective study of 112 patients considered to be at high risk for the formation of urinary tract stones was carried out, through the collection of clinical data and complete metabolic investigation. For data analysis, the Minitab 18® statistical program was used. Results: The mean age was 46.76±13.53 years, and most were overweight/obese with a mean BMI of 29.37±6.14 kg/m2. The Caucasian race prevailed (68.75%) and 66.07% had a family history. The most prominent metabolic alterations were: low urinary volume (77.68%), hypercalciuria (40.18%), hypocitraturia (39.29%), and hyperuricosuria (33.04%). The study identified that the male gender (p=0.02; OR=2.10), BMI (p=0.00; OR=3.50), SAH (p=0.007; OR=1.53), DM (p =0.003; OR=4.99) and dyslipidemia (p=0.002; OR=2.84) represented a strong probability of contributing to the lithiasis event and the main correlations and odds ratio were between hypercalciuria and altered BMI (p=0.001; OR=3.28), hypocitraturia and staghorn calculi (p=0.003; OR=2.21), hyperuricosuria and altered BMI (p=0.017; OR=2.01), hyperoxaluria and altered BMI (p=0.002; OR= 2.81), urinary tract infection and DM (p=0.005; OR=1.73), urinary tract infection and staghorn calculi (p=0.003; OR=1.77), altered parathyroid hormone and altered BMI (p=0.008; OR =2.69) and hyperphosphaturia and altered BMI (p=0.021; OR=1.99). Conclusion: In this study, it was observed that the metabolic syndrome is an important trigger of metabolic changes in kidney stones, and consequently, nephrolithiasis, emphasizing the need to promote or assist public health policies in this population.
Descargas
Referencias
Sakhaee K. Epidemiology and clinical pathophysiology of uric acid kidney stones. J Nephrol; 27: 241–245,2014.
Carpentier X, Chabannes E, Traxer O. Update for the management of kidney stones in 2013. Prog Urol.;24(5):319-26,2014.
Scholz D, Schwille PO, Ulbrich D. Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine. Urol Res; 7:161–170,1979.
Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant;20: 468–469, 2005.
Pak CYC, Preminger GM, Ekeruo W. Biochemical profile of stoneforming patients with diabetes mellitus. Urology; 61:523–527, 2003.
Della GL, Roggi C, Cena H. Diet-induced acidosis and alkali supplementation. Int J Food Sci Nutr.;67(7):754-61, 2016.
Arrabal-Martín M, Domínguez-Amillo A, Cózar-Olmo JM. Factores etiopatogénicos de los diferentes tipos de urolitiasis. Arch Esp Urol.;70(1):40-50, 2017.
Daudon M, Frochot V, Jungers P. Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs;78(2):163-201, 2018.
Bianchi L, Cortegoso VP, Ruberto C. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population. Acta Biomed; 17;89(9-S):76-80, 2018.
Treviño-Becerra A. Uric Acid: The Unknown Uremic Toxin. Contrib Nephrol.; 192:25-33, 2018.
Lancina Martín JA. Estudio metabólico. Cómo hacerlo accesible, útil y generalizado. Arch Esp Urol.; 70 (1): 71-90, 2017.
Minitab®, Quality. Analysis. Results and the Minitab logo are registered trademarks of Minitab, Inc., in the United States and other countries. Additional trademarks of Minitab Inc. can be found at www.minitab.com. All other marks referenced remain the property of their respective owners.
Korkes, F, Da Silva JL, Heilberg, Ita P. Custo do tratamento hospitalar da litíase urinária para o Sistema Único de Saúde brasileiro. Einstein. 9 (1): 518-22, 2011.
Wang S, Zhang Y, Zhang X, Tang Y, Li J. Upper urinary tract stone compositions: the role of age and gender. Int. braz j urol., v. 46, n. 1, p. 70-80,2020.
Wanderley EM, Ferreira VA. Obesidade: uma perspectiva plural. Ciênc. saúde coletiva, v. 15, n. 1, p. 185-194,2010.
Vigitel Brasil 2021 : surveillance of risk and protective factors for chronic diseases by telephone survey : estimates on the frequency and sociodemographic distribution of risk and protective factors for chronic diseases in the capitals of the 26 Brazilian states and in the Federal District in 2021 / Ministry of Health , Secretariat of Health Surveillance, Department of Health Analysis and Surveillance of Noncommunicable Diseases. – Brasilia: Ministry of Health, 2021.
Hsi RS, Kabagambe EK, Shu X. Race- and Sex-related Differences in Nephrolithiasis Risk Among Blacks and Whites in the Southern Community Cohort Study. Urology.;118:36-42, 2018.
García Nieto VM, Perez Suarez G, Moraleda Mesa T. The idiopathic hypercalciuria reviewed. Metabolic abnormality or disease? Nefrologia. 39 (6):592-602, 2019.
Zhang GN, Ouyang JM, Shang YF. Property changes of urinary nanocrystallites and urine of uric acid stone formers after taking potassium citrate. Mater Sci Eng C Mater Biol Appl.;33(7): 4039-45, 2013.
Li X, Li B, Yang L. Treatment of recurrent renal transplant lithiasis: analysis of our experience and review of the relevant literature. BMC Nephrol.; 23;21(1): 238, 2020.
Cupisti A, D’Alessandro C. Características metabólicas e dietéticas em formadores de cálculos renais: uma abordagem nutricional. Braz. J. Nephrol., v. 42, n. 3, p. 271-272, 2020.
Arrabal-Polo MA, Arrabal-Martin M, Garrido-Gomez J. Calcium renal lithiasis: metabolic diagnosis and medical treatment. Sao Paulo Med J.;131(1):46-53,2013.
Letendre J, Cloutier J, Valiquette L. Metabolic evaluation of urinary lithiasis: what urologists should know and do. World J Urol.;33(2):171-8, 2015.
Schwaderer AL, Wolfe AJ. The association between bacteria and urinary stones. Ann Transl Med.;5(2):32,2017.
Pazos PF. Uric Acid Renal Lithiasis: New Concepts. Contrib Nephrol.; 192:116-124, 2018.
Kaaroud H, Goucha R, Ben Abdallah T. Lithiase urinaire héréditaire: expérience d’un service de néphrologie. Prog Urol;29(16):962-973, 2019.
Pradere B, Le Balc'h É, Bensalah K. Lithiases urinaires et pathologies digestives: une revue de la littérature. Prog Urol; 25(10): 557-64, 2015.
Skolarikos A, Seitz C, Türk C. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol.; 67(4): 750-63, 2015.
Kotsiris D, Adamou K, Kallidonis P. Diet and stone formation: a brief review of the literature. Curr Opin Urol.;28(5): 408-413, 2018.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2024 Thiago Milani da Costa; Fabíola de Azevedo Mello, Juliana Machado Avila, Maria Julia Demattei de Melo, Marina Schroeder Iglesias, Sarah Duarte Silveira, Gabriela Reigota Blanco, Marcus Vinícius Pimenta Rodrigues, Renata Calciolari Rossi
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
